Effects of Marijuana on Symptoms of OCD

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Obsessive-Compulsive Disorder

In brief

The purpose of this pilot research study is to test whether certain components of the marijuana plant, known as "cannabinoids", may help to reduce symptoms in patients with OCD. Specifically, patients enrolled in the study will smoke marijuana containing different concentrations of 2 different cannabinoids, THC and CBD. Both of these agents act on the brain's "endocannabinoid system," which has been hypothesized to play a role in OCD. Neither compound is currently FDA-approved for treating OCD.

Key facts

Study ID
NCT03274440
Run by
New York State Psychiatric Institute
People needed
14
Starts
2017-10-01
Expected to finish
2020-10-29
Last updated by the study team
2020-11-18

Who can join

Age: 21 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.